{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:14:29Z","timestamp":1784139269834,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.riam.2013.06.004","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T21:17:06Z","timestamp":1372195026000},"page":"104-108","source":"Crossref","is-referenced-by-count":11,"title":["Yeasts isolated from nosocomial urinary infections: Antifungal susceptibility and biofilm production"],"prefix":"10.1016","volume":"31","author":[{"given":"Alessandra Ribeiro","family":"de Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian Cristiane","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Graciela Iecher","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelen F\u00e1tima","family":"Dalben Dota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcio","family":"Godoy Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezinha Inez Estivalet","family":"Svidzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2013.06.004_bib0005","first-page":"183","article-title":"Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: a five year study","volume":"3","author":"Badiee","year":"2011","journal-title":"Iran J Microbiol"},{"key":"10.1016\/j.riam.2013.06.004_bib0010","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/infdis\/167.5.1247","article-title":"Secular trends in the epidemiology of nosocomial infections in the United States, 1980\u20131990","volume":"167","author":"Beck-Sague","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-3-1","article-title":"Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital","volume":"3","author":"Bruder-Nascimento","year":"2010","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.riam.2013.06.004_bib0020","first-page":"51","article-title":"Infecci\u00f3n sist\u00e9mica nosocomial por levaduras","volume":"18","author":"Cant\u00f3n","year":"2001","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.riam.2013.06.004_bib0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7883\/yoken.JJID.2005.344","article-title":"Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital","volume":"38","author":"Capoor","year":"2005","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0030","series-title":"Method for antifungal disk diffusion susceptibility testing in yeasts. CLSI document M \u2013 44 A, Wayne, PA","author":"Clinical and Laboratory Standards Institute","year":"2002"},{"key":"10.1016\/j.riam.2013.06.004_bib0035","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.riam.2013.06.004_bib0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10096-007-0438-6","article-title":"Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics","volume":"27","author":"Colodner","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jac\/38.3.561","article-title":"Standardization of antifungal susceptibility testing","volume":"38","author":"Cormican","year":"1996","journal-title":"J Antimicrobial Chemother"},{"key":"10.1016\/j.riam.2013.06.004_bib0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.mi.49.100195.003431","article-title":"Microbial Biofilms","volume":"49","author":"Costerton","year":"1995","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.riam.2013.06.004_bib0055","series-title":"Method for determination of minimal inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Discussion document E. Dis. 7.1","author":"European Committee on Antibiotic Susceptibility","year":"2002"},{"key":"10.1016\/j.riam.2013.06.004_bib0060","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1128\/JCM.37.5.1584-1586.1999","article-title":"Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization","volume":"37","author":"Febr\u00e9","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2013.06.004_bib0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1590\/S0037-86822011000500013","article-title":"Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period","volume":"44","author":"Furlaneto","year":"2011","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.riam.2013.06.004_bib0070","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archinte.163.8.972","article-title":"Unnecessary use of antimicrobials in hospitalized patients","volume":"163","author":"Hecker","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.riam.2013.06.004_bib0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.riam.2013.06.004_bib0080","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/AEM.02439-06","article-title":"Biofilm formation by and antifungal susceptibility of Candida isolates from urine","volume":"73","author":"Jain","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.riam.2013.06.004_bib0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7883\/yoken.JJID.2005.263","article-title":"PFGE-based epidemiological study of an outbreak of Candida tropicalis candiduria: the importance of medical waste as a reservoir of nosocomial infection","volume":"58","author":"Jang","year":"2005","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/524071","article-title":"Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact","volume":"46","author":"Kanafani","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/313583","article-title":"Prospective multicenter surveillance study of funguria in hospitalized patients","volume":"30","author":"Kauffman","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0100","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.70.2.878-888.2002","article-title":"Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces","volume":"70","author":"Kuhn","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.riam.2013.06.004_bib0105","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3201\/eid0702.010240","article-title":"Engineering out the risk of infection with urinary catheters","volume":"7","author":"Maki","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0110","first-page":"361","article-title":"Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo","volume":"197","author":"Mock","year":"1998","journal-title":"Pharmacol Treat"},{"key":"10.1016\/j.riam.2013.06.004_bib0115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0974-777X.77288","article-title":"Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in Southern India","volume":"3","author":"Mohandas","year":"2011","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0120","first-page":"1","article-title":"Community-acquired urinary tract infections in a rural area in Jordan: predominant uropathogens and their antimicrobial resistance","volume":"1","author":"Nimri","year":"2010","journal-title":"WebmedCentral: Microbiology"},{"key":"10.1016\/j.riam.2013.06.004_bib0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/432060","article-title":"Emerging fungal diseases","volume":"41","author":"Nucci","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S0104-42302001000300035","article-title":"Infec\u00e7\u00e3o urin\u00e1ria hospitalar por leveduras do g\u00eanero Candida","volume":"47","author":"Oliveira","year":"2001","journal-title":"Rev Ass Med Bras"},{"key":"10.1016\/j.riam.2013.06.004_bib0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7883\/yoken.JJID.2007.302","article-title":"In vitro activities of voriconazole as a triazole derivative and caspofungin as an equinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens","volume":"60","author":"\u00d6z\u00e7elik","year":"2007","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0140","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JCM.44.5.1740-1743.2006","article-title":"Clinical significance of azole antifungal drug cross-resistance in Candida glabrata","volume":"44","author":"Panackal","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2013.06.004_bib0145","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1590\/S0074-02762005000800016","article-title":"Candida colonization in intensive care unit patients\u2019 urine","volume":"100","author":"Passos","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.riam.2013.06.004_bib0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jinf.2007.06.010","article-title":"Factors associated with candiduria and related mortality","volume":"55","author":"Paul","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.riam.2013.06.004_bib0155","first-page":"74","article-title":"Azole antifungal drug cross-resistance: mechanisms, epidemiology, and clinical significance","volume":"1","author":"Pfaller","year":"2007","journal-title":"J Invasive Fungal Infect"},{"key":"10.1016\/j.riam.2013.06.004_bib0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1470-9465.2004.t01-1-00844.x","article-title":"Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida","volume":"10","author":"Pfaller","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.riam.2013.06.004_bib0165","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","article-title":"Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2013.06.004_bib0170","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1128\/JCM.00409-07","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing","volume":"45","author":"Pfaller","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2013.06.004_bib0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/CMR.19.2.435-447.2006","article-title":"Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing","volume":"19","author":"Pfaller","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.riam.2013.06.004_bib0180","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1128\/JCM.42.8.3607-3612.2004","article-title":"Comparison of results of fluconazole disk diffusion testing for Candida with results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2013.06.004_bib0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4067\/S0716-10182012000200005","article-title":"Susceptibilidad a azoles y anfotericina B de aislados de Candida spp. Experiencia de una red de salud universitaria, entre 2004 y 2010","volume":"29","author":"Porte","year":"2012","journal-title":"Rev Chil Infect"},{"key":"10.1016\/j.riam.2013.06.004_bib0190","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1601-0825.2007.01424.x","article-title":"Biofilm lifestyle of Candida: a mini review","volume":"14","author":"Seneviratne","year":"2008","journal-title":"Oral Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/CMR.12.1.40","article-title":"Current and emerging azole antifungal agents","volume":"12","author":"Sheehan","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.riam.2013.06.004_bib0200","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JCM.40.4.1244-1248.2002","article-title":"Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources","volume":"40","author":"Shin","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.riam.2013.06.004_bib0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/13693780701601736","article-title":"Nosocomial candiduria in women undergoing urinary catheterization. Clonal relationship between strains isolated from vaginal tract and urine","volume":"45","author":"Silva","year":"2007","journal-title":"Med Mycol"},{"key":"10.1016\/j.riam.2013.06.004_bib0210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/510432","article-title":"Caspofungin in the treatment of symptomatic candiduria","volume":"44","author":"Sobel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/313580","article-title":"Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo","volume":"30","author":"Sobel","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2013.06.004_bib0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1439-0507.2004.00971.x","article-title":"In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study)","volume":"47","author":"Swinne","year":"2004","journal-title":"Mycoses"},{"key":"10.1016\/j.riam.2013.06.004_bib0225","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin Microbial Rev"},{"key":"10.1016\/j.riam.2013.06.004_bib0230","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.riam.2012.01.001","article-title":"Epidemiological and clinical characteristics of nosocomial candidiasis in university hospitals in Cuiab\u00e1 \u2013 Mato Grosso, Brazil","volume":"29","author":"Yamamoto","year":"2012","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.riam.2013.06.004_bib0235","series-title":"The yeasts: a taxonomic study","first-page":"77","article-title":"Methods for the isolation, maintenance and identification of yeasts","author":"Yarrow","year":"1998"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140613000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140613000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T23:29:37Z","timestamp":1715556577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140613000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1130140613000624"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2013.06.004","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}